<- Go Home
Gyroscope Therapeutics Holdings PLC
As of February 18, 2022, operates as a subsidiary of Novartis AG.
Market Cap
N/A
Volume
N/A
Cash and Equivalents
$58.6M
EBITDA
-$86.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$489.2K
Profit Margin
87.20%
52 Week High
N/A
52 Week Low
N/A
Dividend
N/A
Price / Book Value
N/A
Price / Earnings
N/A
Price / Tangible Book Value
N/A
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$89.0M
Return on Equity
298.41%
Return on Assets
-93.58
Cash and Short Term Investments
$58.6M
Debt
N/A
Equity
$56.7M
Revenue
$561.0K
Unlevered FCF
-$40.4M
Sector
Biotechnology
Category
N/A